RSS

biotechnology

Biotechnology company Lonza has announced an initiative with GE Healthcare in which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China (CN). Read more

News

Biotechnology company, Oncolytics Biotech, has announced a clinical collaboration with an academic research group dedicated to clinical and translational research in breast cancer, SOLTI. Read more

News

Commercial stage biotechnology acceleration development company, Q BioMed, with licensor of Strontium 89 Chloride, BioNucleonics, have announced the submission of a supplemental regulatory filing for a new manufacturing facility. Read more

News

Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more

News

Independent provider of integrated drug discovery and pre-clinical services and expertise, Sygnature Discovery, has announced the next stage of its expansion plans with the addition of a new facility at Alderley Park. Read more

News

Biotechnology company, Bavarian Nordic, has revealed positive data from the extension study of its Phase II study investigating its universal respiratory syncytial virus (RSV) vaccine, MVA-BN RSV, in older adults. Read more

News

Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. Read more

News

Commercial stage biotechnology acceleration development company, Q BioMed, has extended its option agreement with Washington University in St Louis for a novel companion biomarker for monitoring glaucoma and initiation of a clinical study. Read more

News

Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. Read more

News

Emergex Vaccines Holding (Emergex) — a biotechnology company — has been awarded with a grant of £979,318 from Innovate UK to progress its universal flu vaccine programme through preclinical development. Read more

News

Producer of tailor-made recombinant glycoproteins and gene therapy vectors, CEVEC Pharmaceuticals, and global biotechnology company, CSL, have announced an exclusive licensing agreement to produce a recombinant C1 Esterase Inhibitor. Read more

News

Biotechnology company, Genmab, has announced that the FDA has approved the use of DARZALEX (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) for the treatment of patients with newly diagnos Read more

News

Biotechnology company, Takara Bio USA (TBUSA), has teamed up with smartphone diagnostics specialists, Novarum, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants. Read more

Technology

Orchard Therapeutics, a commercial and clinical-stage company, has opened a new US office located in Boston’s Seaport District, building upon the company’s footprint in London as well as Foster City and Menlo Park, California. Read more

News

Innovative biotechnology company, ADC Biotechnology, has secured £1.14 million in funding from Downing LLP to assist the company in its US expansion and aid in the development of an advanced bioconjugation method. Read more

News

A collaborative partnership has been entered into by Sartorius Stedim Biotech and Penn State University for the advancement of multidisciplinary teaching and research in biotechnology. Read more

News

Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. Read more

News

Biotechnology company, Shire, has announced a professional training development collaboration with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland. Read more

News

Commercial stage biotechnology acceleration development company, Q BioMed, and Bio-Nucleonics, licensor of Strontium-89 Chloride, have filed for regulatory approval of a new manufacturing facility by the US Food and Drug Administration (FDA). Read more

Technology

Clinical stage biotechnology company, Destiny Pharma, has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) for its lead clinical drug candidate, XF-73. Read more

News